Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background: Early and accurate diagnosis of ischaemic stroke (IS) requires the use of an optimized biomarker. Exosomal microRNAs have the potential to serve as biomarkers owing to their stability and specificity. We investigated the expression levels of plasma-derived exosomal microRNA-21-5p and microRNA-30a-5p in the different phases of IS. Methods: One hundred forty-three patients with IS and 24 non-stroke controls were enrolled. The patients were divided into the following 5 groups: 1 group for the hyperacute phase IS (HIS, within 6 h); two for the acute phase IS (AIS, including days 1–3 and days 4–7); one for the subacute phase IS (SIS, days 8–14); and one for the recovery phase IS (RIS, days >14). Plasma exosomes were isolated using a QIAGEN exoRNeasy kit and examined by transmission electron microscopy, nanoparticle tracking, and flow cytometry. The expression levels of miRNA-21-5p and miRNA-30a-5p were detected by quantitative real-time polymerase chain reaction. Results: The plasma exosomal miR-21-5p levels in SIS and RIS were significantly higher than that in controls (p < 0.05 and p < 0.01 respectively). The levels of miR-30a-5p in HIS were significantly higher (p < 0.05) and in AIS (days 1–3) were lower than that in controls (p < 0.05). In AIS (days 1–3), both miRNAs were decreased compared with the HIS group (p = 0.053 and 0.001, respectively). The area under the curve (AUC) of the miR-21-5p was 0.714 for SIS (95% CI 0.570–0.859, p = 0.007), 0.734 for RIS (95% CI 0.596–0.871, p = 0.003); the AUC of the miR-30a-5p was 0.826 for HIS (95% CI 0.665–0.988, p = 0.001), 0.438 for AIS (days 1–3; 95% CI 0.240–0.635, p = 0.516). Conclusions: The plasma-derived exosomal miR-21-5p and miRNA-30a-5p in combination are promising biomarkers for diagnosing IS and distinguishing among HIS, SIS, and RIS, especially miRNA-30a-5p for the diagnosis of the HIS phase. Our results provide a new reference for clinicians to apply in early-stage diagnosis and identifies the possible value of biomarkers for IS thrombolysis therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Circulating EVs have proven to be valuable biomarkers for the early, noninvasive diagnosis of ischemic stroke [301–304].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [304]
In the citing paper
“Our data also showed the overexpression of miRNA-21-3p and miRNA-30a-5p (Wang et al., 2018), but they did not reach the significance threshold.”
From Acute Cerebral Ischemia Increases a Set of Brain-Specific miRNAs in Serum Small Extracellular Vesicles (2022) · cites this paper as Wang et al., 2018
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Self-citationCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
Exosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
Acute Stroke Intervention: A Systematic Review
Prabhakaran, S., Ruff, I., & Bernstein, R. A. (2015) · JAMA · doi:10.1001/jama.2015.3058 · Cited by 671
Cited by
Role of Exosomes in Central Nervous System Diseases
Liu, W., Bai, X., Zhang, A., Huang, J., Xu, S., & Zhang, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00240 · Cited by 221
Circulating microRNAs: Biomarkers of disease
Wu, Y., Li, Q., Zhang, R., Dai, X., Chen, W., & Xing, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.008 · Cited by 178
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan, Y., Chen, Z., & Zhang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03493-6 · Cited by 134
Emerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
Feng, J., Zhang, Y., Zhu, Z., Gu, C., Waqas, A., & Chen, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703989 · Cited by 106
Rahmani, A., Saleki, K., Javanmehr, N., Khodaparast, J., Saadat, P., & Nouri, H. R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101106 · Cited by 98
Metadata
- Authors
- Wang, W., Li, D.-B., Li, R.-Y., Zhou, X., Yu, D.-J., Lan, X.-Y., Li, J.-P., & Liu, J.-L.
- Affiliations
- Guangxi Medical University (CN)
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 45
- Issue
- 5-6
- Pages
- 204-212
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W2795447768
- Cited by
- 113
- References
- 48
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 16 · 2023: 11 · 2022: 25 · 2021: 23 · 2020: 12 · 2019: 5 · 2018: 2
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cerebrovascular Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- ischemic stroke, hyperacute stroke, acute stroke, exosomal microRNAs, miR-21-5p, miR-30a-5p, plasma exosomes, stroke biomarkers, subacute stroke, diagnostic accuracy, blood-based biomarkers, exosome isolation and characterization, nanoparticle tracking analysis, flow cytometry, transmission electron microscopy
- MeSH terms
- Aged, Brain Ischemia, Female, Genetic Markers, Humans, Male, Middle Aged, Predictive Value of Tests, Time Factors, Down-Regulation, Case-Control Studies, Stroke, MicroRNAs, Microscopy, Electron, Transmission, Exosomes, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p. https://app.cochat.ai/papers/10.1159/000488365
- The paper
- Wang, W., Li, D.-B., Li, R.-Y., Zhou, X., Yu, D.-J., Lan, X.-Y., Li, J.-P., & Liu, J.-L. (2018). Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p. Cerebrovascular Diseases. https://doi.org/10.1159/000488365
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.